-The Times of India NEW DELHI: Four million households in Maoist-affected districts are likely to get BPL status without having to wait for another two years when the Socio-Economic Caste Census is expected to be completed. The list of BPL will be revised based on the findings of the census. The shortcut inclusion in the 82 Maoist-affected districts is aimed at making the poor, who fell between the cracks of the poverty...

-Down to Earth Report by children's non-profit links childhood malnourishment to educational performance, adult income and GDP Malnutrition decrease the gross domestic product (GDP) in low- and middle-income countries, says a report by international non-profit Save the Children. Malnutrition affects educational development, physical productivity and health, and also perpetuates inequalities, such as those created by caste in India, says the report. The report, Food for thought: Tackling child malnutrition to unlock potential...

-Live Mint Rural development minister Jairam Ramesh said the committee's recommendations will be accepted New Delhi: A government committee has recommended issuing below-poverty-line (BPL) cards to all 4 million households in 22 backward districts that are affected by the Maoist insurgency. The committee, set up by the rural development ministry, also recommended the inclusion in another 34 such districts of households that are headed by a scheduled caste or scheduled tribe member,...

-The United Nations A United Nations report released today stresses the importance of providing meals for schoolchildren, particularly in times of crisis, and notes that this is still lacking in many developing countries. "School feeding assures that where quality education is available, children are able to take advantage of the opportunity to learn," said the Executive Director of the World Food Programme (WFP), Ertharin Cousin. "It's an investment that pays off in the...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...